Citigroup
HSCS icon

Citigroup’s Heart Test Laboratories HSCS Stock Holding History

Citigroup’s Portfolio HSCS Stock Details HSCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7K Buy
+5,859
New +$12K ﹤0.01% 5195
2025
Q4 		– Sell
-14
Closed -$49 – 6222
2025
Q3 		$49 Buy
+14
New +$51 ﹤0.01% 5855

Other funds holding HSCS

TA
TFB Advisors Overland Park, Kansas $227M AUM 26.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ASW
Astoria Strategic Wealth Conroe, Texas $438M AUM 16.79% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TWM
Tradition Wealth Management Edina, Minnesota $1.64B AUM 26.59% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citigroup's HSCS Position: Q2 2026 in Review

Citigroup opened a new position in Heart Test Laboratories (HSCS) in Q2 2026: 5,859 shares worth $14.7K. The stake represents ﹤0.01% of the portfolio and ranks #5195 among its holdings. This is a return to the name: Citigroup previously reported a position in HSCS as recently as Q3 2025.

Citigroup first reported a position in HSCS in Q3 2025 and has held it in 2 quarters since. 16 funds tracked by Wall St. Rank hold HSCS as of Q2 2026.

  • Citigroup held 5,859 shares of Heart Test Laboratories worth $14.7K as of Q2 2026.
  • Heart Test Laboratories was a new Citigroup position in Q2 2026.
  • Heart Test Laboratories made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5195 holding.
  • Citigroup first reported a position in Heart Test Laboratories in Q3 2025 and has held it in 2 quarters since.
  • 16 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.